MDA/2004/028 - Flexible and rigid endoscopes

Document details:

Type: Medical Device Alert
Series No: MDA/2004/028
Audience: Healthcare professionals
Published:
Format:
Size: A4
Pages: 4
Price: free
ISBN/ISSN:
Author:
Copyright: Crown
   

1. Page 1

Ref. MDA/2004/028
Issued: 23 June 2004

IMMEDIATE ACTION
ACTION  
UPDATE  
INFORMATION REQUEST  


  Further Information
DEVICE:
Flexible and rigid endoscopes
 
PROBLEM:
Risk of transmission of infection because of inadequate decontamination.

 *

ACTION BY:
Staff involved in:

  • the reprocessing and use of endoscopes
  • the specification for purchase and purchasing of endoscopes

Assessments of reprocessing facilities and equipment should involve the infection control team, risk manager, health and safety advisor and the trust decontamination lead person (or a senior manager).

 
ACTION:
Carry out an immediate assessment of all endoscope decontamination processes.

 

*

DISTRIBUTED to:

NHS Trusts (England) - Chief Executives
Healthcare Commission (CHAI) - Headquarters
Primary Care Trusts (England) - Chief Executives
Health Protection Agency (HPA) - Director

 

 

*
CONTACTS:
Details of MHRA contacts for technical and clinical aspects.

*

FEEDBACK REQUIREMENTS:
If a problem is identified with the endoscope decontamination process that could raise concerns for public health or infection control, please inform the local consultant in communicable disease control. Report any equipment problems relating to the decontamination of endoscopes or decontamination aspects of instructions for use to MHRA.
 


* Further information supplied in the following pages.

2. Page 2

PROBLEM:
The MHRA is aware of cases of inadequate decontamination of endoscopes, which have been cleaned and disinfected using manual and/or automatic processes.

Examples of inadequate decontamination include:

  • the use of connection sets that are not designated for a particular endoscope and the automated endoscope reprocessor (AER)
  • failure to decontaminate all channels including those that have not been used during the procedure
  • where required, failure to manually decontaminate auxiliary channels prior to automated reprocessing
  • the flushing, but not high level disinfecting, of auxiliary channels e.g. elevator wire channel or auxiliary irrigation channel.

These practices could result in an increased risk of transmission of infection between patients.

All endoscope channels must be decontaminated after each procedure even if they have not been used during that procedure (e.g. auxiliary irrigation channels).

Some endoscopes (particularly older models) have channels that are not accessible to automated decontamination processes. The channels of these models must be manually cleaned and disinfected according to the manufacturer's instructions.

The effective use of an AER requires the endoscope to be connected correctly to the machine using designated connection sets for that particular model of endoscope. These connection sets are normally supplied by the manufacturer of the reprocessing equipment. All decontamination processes using AERs must be validated.

ACTION:

  • Carry out an immediate assessment of all endoscope decontamination processes. In particular:
  • Identify endoscopes that have channels that cannot be decontaminated in an AER. These channels must be manually cleaned and disinfected following the manufacturer's instructions after every use of the endoscope; it is not acceptable to omit either phase from the process.
  • Identify scopes with channels that may not be used during every procedure (e.g. auxiliary irrigation channel). These channels must be included in the decontamination cycle (manual or automated) after every use of the endoscope.
  • Ensure that connection sets are fully compatible with both the endoscope and the AER.
  • Check that all channels of the endoscope are accessible to the decontamination process and that the process is validated for each type of endoscope.
  • If inadequate decontamination is identified contact the consultant in communicable disease control (CCDC) at your local health protection unit and consider the need for screening patients.
  • Follow the endoscope and AER manufacturers' advice and instructions for use regarding the decontamination of endoscopes.
  • When specifying for purchase and before purchasing a new endoscope check that it can be reprocessed using the decontamination processes available.
  • Do not put endoscopes into service without a validated reprocessing procedure being in place.

3. Page 3

ACTION (continued):
Further advice is available in:

Medical Devices Agency. Device Bulletin DB2002(05) 'Decontamination of endoscopes' 2002. www.mhra.gov.uk
British Society of Gastroenterology (2003). 'Endoscopy guidelines'. www.bsg.org.uk
NHS Estates (1997). Health Technical Memorandum 2030 'Washer Disinfectors'. www.nhsestates.gov.uk
Controls Assurance Standards. 'Decontamination of reusable medical devices', 'Medical devices management'. www.hcsu.org.uk

DEADLINES FOR THE SAFETY ALERT BROADCAST SYSTEM

Deadline (Action underway): 07 July 2004
Action plan to be agreed and actions started.
Deadline (Action complete): 18 August 2004
All actions to be completed.


DISTRIBUTION:
Please bring this notice to the attention of all who need to know or be aware of it. This will include distribution by:

TRUSTS to:

  • Liaison officers (for onward distribution)
  • Clinical governance leads
  • Decontamination leads
  • Director of infection prevention and control
  • Endoscopy suite managers
  • Gastroenterologists
  • Health and safety officers
  • Infection control doctors
  • Infection control nurses
  • Intensive care units
  • Medical directors
  • Nurse endoscopists
  • Nursing executive directors
  • Out patient departments
  • Physicians
  • Purchasing managers
  • Risk managers
  • Sterilise services managers
  • Surgeons
  • Theatre managers
  • Theatre nurses
  • Urologists

HEALTHCARE COMMISSION (CHAI) to:

  • Headquarters (for onward distribution)
  • Clinics
  • Hospitals in the independent sector
  • Private medical practitioners

PRIMARY CARE TRUSTS to:

  • Liaison officers (for onward distribution)
  • Clinical governance leads
  • Community hospitals
  • Directors of public health
  • Endoscopy suites
  • General medical practitioners undertaking endoscopy
  • Lead nurses

HEALTH PROTECTION AGENCY to:

  • Liaison officers (for onward distribution)
  • Consultants in communicable disease control
  • Health protection nurses

CONTACTS:
Enquiries to the MHRA should quote reference number 2004/005/005/291/427 and be addressed to:

Technical aspects: Clinical aspects:

Allan Hidderley, Ian Smith or Jill Dhell
Medicines & Healthcare products Regulatory Agency
Hannibal House
Elephant and Castle
London SE1 6TQ

Tel: 020 7972 8172 / 8306 / 8268
Fax: 020 7972 8106

E-mail:
allan.hidderley@mhra.gsi.gov.uk
ian.smith@mhra.gsi.gov.uk
jill.dhell@mhra.gsi.gov.uk

Jonathan Plumb
Medicines & Healthcare products Regulatory Agency
Hannibal House
Elephant and Castle
London SE1 6TQ

Tel: 020 7972 8128
Fax: 020 7972 8103

E-mail:
jonathan.plumb@mhra.gsi.gov.uk



© Crown Copyright 2004

Page last modified: 07 February 2008